Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Interactions of HIV-1 Capsid with Host Factors and Their Implications for Developing Novel Therapeutics
Shentian Zhuang, Bruce E. Torbett
Viruses (2021) Vol. 13, Iss. 3, pp. 417-417
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Nuclear Capsid Uncoating and Reverse Transcription of HIV-1
Thorsten G. Müller, Vojtěch Žíla, Bárbara Müller, et al.
Annual Review of Virology (2022) Vol. 9, Iss. 1, pp. 261-284
Open Access | Times Cited: 64
A functional map of HIV-host interactions in primary human T cells
Joseph Hiatt, Judd F. Hultquist, Michael McGregor, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 41
New Approved Drugs Appearing in the Pharmaceutical Market in 2022 Featuring Fragments of Tailor-Made Amino Acids and Fluorine
Nana Wang, Haibo Mei, Gagan Dhawan, et al.
Molecules (2023) Vol. 28, Iss. 9, pp. 3651-3651
Open Access | Times Cited: 29
Rotten to the core: antivirals targeting the HIV-1 capsid core
William M. McFadden, Alexa A. Snyder, Karen A. Kirby, et al.
Retrovirology (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 50
Fluorine in the pharmaceutical industry: Synthetic approaches and application of clinically approved fluorine-enriched anti-infectious medications
Zhen-Xi Niu, Jing Hu, Jinfeng Sun, et al.
European Journal of Medicinal Chemistry (2024) Vol. 271, pp. 116446-116446
Closed Access | Times Cited: 7
Potent Long-Acting Inhibitors Targeting the HIV-1 Capsid Based on a Versatile Quinazolin-4-one Scaffold
Eric P. Gillis, Kyle Parcella, Michael Bowsher, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 3, pp. 1941-1954
Closed Access | Times Cited: 15
HIV-1 capsid is the key orchestrator of early viral replication
Vojtěch Žíla, Thorsten G. Müller, Bárbara Müller, et al.
PLoS Pathogens (2021) Vol. 17, Iss. 12, pp. e1010109-e1010109
Open Access | Times Cited: 32
Genomic Variation and Diversification in Begomovirus Genome in Implication to Host and Vector Adaptation
Deepti Nigam
Plants (2021) Vol. 10, Iss. 8, pp. 1706-1706
Open Access | Times Cited: 30
The Role of Capsid in HIV-1 Nuclear Entry
Anabel Guedán, Eve R. Caroe, Genevieve C. R. Barr, et al.
Viruses (2021) Vol. 13, Iss. 8, pp. 1425-1425
Open Access | Times Cited: 27
HIV Capsid Protein Genetic Diversity Across HIV-1 Variants and Impact on New Capsid-Inhibitor Lenacapavir
Paloma Troyano-Hernáez, Roberto Reinosa, África Holguín
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 22
Cyclophilin A Regulates Tripartite Motif 5 Alpha Restriction of HIV-1
Tingting Wang, Daniel Becker, Augustin Penda Twizerimana, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 495-495
Open Access
Cell-free assays reveal that the HIV-1 capsid protects reverse transcripts from cGAS immune sensing
Tiana M. Scott, Lydia M. Arnold, Jordan A. Powers, et al.
PLoS Pathogens (2025) Vol. 21, Iss. 1, pp. e1012206-e1012206
Open Access
Effects of GS-CA1 on nuclear envelope-associated early HIV-1 infection steps
Amita Singh, Victor Fourcassié, Karen Cristine Gonçalves dos Santos, et al.
Frontiers in Virology (2025) Vol. 5
Open Access
Considerations for capsid-targeting antiretrovirals in pre-exposure prophylaxis
William M. McFadden, Mia Færch, Karen A. Kirby, et al.
Trends in Molecular Medicine (2025)
Closed Access
Synthesis and clinical application of new drugs approved by FDA in 2022
Jingyi Zhang, Yatao Wang, Lu Sun, et al.
Molecular Biomedicine (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 9
State of the ART (antiretroviral therapy): Long-acting HIV-1 therapeutics
S Ravichandran, William M. McFadden, Alexa A. Snyder, et al.
Global Health & Medicine (2024)
Closed Access | Times Cited: 3
Targeting the HIV-1 and HBV Capsids, an EnCore
William M. McFadden, Stefan G. Sarafianos
Viruses (2023) Vol. 15, Iss. 4, pp. 896-896
Open Access | Times Cited: 7
May I Help You with Your Coat? HIV-1 Capsid Uncoating and Reverse Transcription
Laura Arribas, Luis Menéndez‐Arias, Gilberto Betancor
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7167-7167
Open Access | Times Cited: 2
From design to biological mechanism evaluation of phenylalanine-bearing HIV-1 capsid inhibitors targeting a vital assembly interface
Shujing Xu, Lin Sun, Waleed A. Zalloum, et al.
Chinese Chemical Letters (2022) Vol. 34, Iss. 3, pp. 107611-107611
Closed Access | Times Cited: 12
Synthetic approaches and application of clinically approved small-molecule Anti-HIV drugs: An update
Lu Sun, Peng Nie, Luan Li, et al.
European Journal of Medicinal Chemistry (2023) Vol. 261, pp. 115847-115847
Closed Access | Times Cited: 6
Selection and identification of an RNA aptamer that specifically binds the HIV-1 capsid lattice and inhibits viral replication
Paige R. Gruenke, Rachna Aneja, Sarah Welbourn, et al.
Nucleic Acids Research (2021) Vol. 50, Iss. 3, pp. 1701-1717
Open Access | Times Cited: 13
Highlights on the Development, Related Patents, and Prospects of Lenacapavir: The First-in-Class HIV-1 Capsid Inhibitor for the Treatment of Multi-Drug-Resistant HIV-1 Infection
Tafadzwa Dzinamarira, Mazen Almehmadi, Ahad Amer Alsaiari, et al.
Medicina (2023) Vol. 59, Iss. 6, pp. 1041-1041
Open Access | Times Cited: 5
Towards in situ high-resolution imaging of viruses and macromolecular complexes using cryo-electron tomography
Yixin Huang, Yuxin Zhang, Tao Ni
Journal of Structural Biology (2023) Vol. 215, Iss. 3, pp. 108000-108000
Closed Access | Times Cited: 5
HIV‐1 replication requires optimal activation of the unfolded protein response
Anjali Tripathi, Kruthika Iyer, Debashis Mitra
FEBS Letters (2023) Vol. 597, Iss. 23, pp. 2908-2930
Closed Access | Times Cited: 4
Discovery of low‐molecular‐weight phenylalanine derivatives as novel HIV capsid modulators with improved antiretroviral activity and metabolic stability
Xiangyi Jiang, Zhen Gao, Prem P. Sharma, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 4
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top